Learn more about Össur's Board of Directors

Board of Directors. Ossur.com

All the members of the Board of Directors were elected at the Annual General Meeting for a term of one year.

Member of the Board of Directors since the year 2005

Master’s degree in Business Administration from the University of Aarhus

ATP Langsigtet Dansk Kapital, member of Advisory Board

Central Board of the Confederation of Danish Industry, member

Additional duties related to William Demant Invest A/S: 

Niels has extensive leadership experience from major international companies. His competencies include business management and in-depth knowledge of financial matters, accounting, risk management and M&A. He has broad experience from the global healthcare industry.

He is currently CEO of William Demant Invest A/S and prior to that, he was President & CEO of Demant A/S (formerly William Demant Holding A/S).

Niels has no interest links with Össur’s main clients or competitors. Niels is a dependent member of the Board as he represents the interest of Össur’s controlling shareholder, William Demant Invest A/S.

Member of the Board of Directors since the year 2008   

Doctorate in Industrial Relations from the London School of Economics   

Dr. Svafa Grönfeldt is a Professor of Practice at the Massachusetts Institute of Technology. She is a founding member of MIT’s newest innovation accelerator DesignX focused on developing new ventures created at MIT. Svafa is the cofounder of The MET fund, a Cambridge based seed investment fund. Previous positions include executive leadership positions at two global life science companies where she served as Chief Organizational Development Officer of Alvogen and Deputy to the CEO of Actavis Group. Svafa is a former President of Reykjavik University.

Svafa holds no shares nor share options in Össur.

Svafa has no interest links with Össur’s main clients, competitors, or major shareholders. Svafa is considered a dependent member of the Board due to her long tenure on the Board.

Member of the Board of Directors since the year 2009   

Master’s degree in Business Administration from the Copenhagen Business School

Arne has spent his entire career with Demant A/S in various and expanding roles throughout the world. After working as an interim General Manager of Oticon Australia Pty Ltd, Arne assumed, in 1996, his current position as President of Diagnostics and Communications in Demant, which has operations worldwide.

Arne holds no shares nor share options in Össur.

Arne has no interest links with Össur’s main clients or competitors. Arne is a dependent member of the Board as he represents the interest of Össur’s controlling shareholder, William Demant Invest A/S.

Member of the Board of Directors since the year 2021     

Medical degree in Medicine and Surgery from Universidad Nacional Autonoma de Mexico

AMRPA and Einstein Healthcare Network, Board member

Dr. Alberto Esquenazi, MD, serves as the John Otto Haas Chair of the Department of Physical Medicine and Rehabilitation at MossRehab in Philadelphia and is the Chief Medical Officer as well as Director of the Gait and Motion Analysis Laboratory and Clinical Director of the Regional Amputee Center. He is Professor of PM&R at Jefferson School of Medicine and the SVP, Enterprise Rehabilitation and Postacute Care Network. Alberto is the past president of the American Academy of PM&R. He has published widely and is a member of national and international professional, educational, and research societies.

Alberto holds no shares nor share options in Össur.

Alberto has no interest links with Össur’s main clients, competitors, or major shareholders. Alberto is an independent member of the Board.

Member of the Board of Directors since the year 2013    

Master’s degree (Pharm.) from Copenhagen University

Reykjavik University, Chairman of RU Council and Chairman of the Board of Directors

Guðbjörg Edda’s previous positions include President & EVP Strategic Projects of Actavis Plc in Iceland, a global integrated specialty pharmaceutical company. She was Deputy CEO and EVP of Third Party Sales at Actavis Group hf., Deputy CEO, Head of R&D, Assistant Managing Director, Development Manager, Regulatory Manager and Marketing Manager at Delta hf. and Medical Representative at Pharmaco hf. She was the President of the European Generic Medicines Association from 2011-2013.

Gudbjörg Edda holds no share options in Össur.

Gudbjörg Edda has no interest links with Össur’s main clients, competitors, or major shareholders. Gudbjörg Edda is an independent member of the Board.

The Board of Directors is the supreme authority in Össur’s affairs between Shareholders’ Meetings. The Board has various roles and responsibilities, including establish goals for the Company and formulate the policy and strategy to achieve those goals, hire a CEO to manage the Company’s daily operations, supervise the Company’s activities and ensure that the Company’s organization and operations are in good and proper order, ensure adequate surveillance of the accounting and financial management of the Company, and evaluate the Company’s capital structure as well as the performance of the Board and the CEO. The Board’s roles and responsibilities are further described in the Board’s rules of procedure, which are available here.

Board of Directors

Niels Jacobsen

Dr. Svafa Grönfeldt

Arne Boye Nielsen

Dr. Alberto Esquenazi

Gudbjörg Edda Eggertsdóttir